Stagnate same-store sales and an non-cash impairment dragged down the Canadian company’s results.
The post High Tide posts C$3.8 million loss for fiscal year 2024 appeared first on Green Market Report.
Category: Business
Nextleaf loss widens despite 66% revenue growth in 2024
Share-based compensation expenses weighed on the company’s bottom line.
The post Nextleaf loss widens despite 66% revenue growth in 2024 appeared first on Green Market Report.
Safe Harbor Financial CEO to step down, successor named
The cannabis banking firm tapped an industry turnaround expert as new chief executive as Seefried plans retirement.
The post Safe Harbor Financial CEO to step down, successor named appeared first on Green Market Report.
Optimi Health beefs psychedelic footprint, nabs new funding
The Canadian drug maker reported its largest MDMA capsule production run to date following more expansion overseas.
The post Optimi Health beefs psychedelic footprint, nabs new funding appeared first on Green Market Report.
Scotts’ Hawthorne unit posts profit despite sharp sales drop
Despite Hawthorne’s improved performance, Scotts expects the division’s sales to decline by mid-single digits this fiscal year.
The post Scotts’ Hawthorne unit posts profit despite sharp sales drop appeared first on Green Market Report.
Safe, Safer, Safest? Cannabis banking bill isn’t dead
Unfortunately, the Farm Bill is not seen as an urgent item for politicians to address.
The post Safe, Safer, Safest? Cannabis banking bill isn’t dead appeared first on Green Market Report.
New Colorado anti-cannabis campaign highlights need for political vigilance
The campaign, which was funded with cannabis tax dollars, used racist imagery and debunked myths about the drug.
The post New Colorado anti-cannabis campaign highlights need for political vigilance appeared first on Green Market Report.
FDA approves J&J’s esketamine as stand-alone depression treatment
The move expands access to the novel mental health treatment, which has shown rapid symptom improvement for the past few years now.
The post FDA approves J&J’s esketamine as stand-alone depression treatment appeared first on Green Market Report.
Atai, Awakn make progress on treatments for alcohol use disorder
Both companies have zeroed in on a disorder that affects millions of people with the potential for huge financial success.
The post Atai, Awakn make progress on treatments for alcohol use disorder appeared first on Green Market Report.
Cannabis wants to join the list of ‘debanking’ victims, but it’s not so simple
The Trulieve CEO is trying to paint the cannabis sector as a victim of partisan efforts by large financial institutions.
The post Cannabis wants to join the list of ‘debanking’ victims, but it’s not so simple appeared first on Green Market Report.